CONSTELLATION PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
08 Jul 2020	Form 3: Humphrey Jeffrey, Chief Medical Officer No securities owned
06 Apr 2020	Form 3: Levy Richard S, Director No securities owned
23 Mar 2020	Form 3: Column Group III, Lp, 10% owner and 2 others Holds 36,135 shares of Common Stock
04 Oct 2019	Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 7 others Holds 3,616,873 shares of Common Stock
20 Feb 2019	Form 3: Braunstein Scott, Director Holds 0 shares of No securities are beneficially owned
30 Nov 2018	Form 3: Trojer Patrick, Chief Scientific Officer Holds 10,277 shares of Common Stock
05 Sep 2018	Form 3: Hoerter Steven L., Director Holds 0 shares of No securities are beneficially owned
05 Sep 2018	Form 3: Trehu Elizabeth, Director Holds 0 shares of No securities are beneficially owned
18 Jul 2018	Form 3: Glaxosmithkline Plc, 10% owner
18 Jul 2018	Form 3: Alexandria Venture Investments, Llc, 10% owner
18 Jul 2018	Form 3: Flynn James E, 10% owner and 3 others
18 Jul 2018	Form 3: Tepper Robert I, Director Holds 11,050 shares of Common Stock
18 Jul 2018	Form 3: Third Rock Ventures Lp, 10% owner and 4 others Holds 11,050 shares of Common Stock
18 Jul 2018	Form 3: Column Group L P, 10% owner and 7 others Holds 11,051 shares of Common Stock
18 Jul 2018	Form 3: Casdin Capital, Llc, 10% owner and 5 others
18 Jul 2018	Form 3: Orbimed Advisors Llc, 10% owner and 2 others
18 Jul 2018	Form 3: Svennilson Peter, Director Holds 11,051 shares of Common Stock
18 Jul 2018	Form 3: Spur Ventures II, Lp, 10% owner and 1 other
18 Jul 2018	Form 3: Precision Onco Ltd, 10% owner
18 Jul 2018	Form 3: Topspin Fund L.p., 10% owner and 3 others

Comments